Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Scientific Reports|August 9, 2016
Miniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic responseLucia De Rosa, Federica Finetti, Donatella Diana, et al.
Plos One|July 21, 2012
Pharmacological inhibition of microsomal prostaglandin E synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesisFederica Finetti, Erika Terzuoli, Elena Bocci, et al.
Biochemical Pharmacology|May 5, 2012
Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesisFederica Finetti, Anna Basile, Domenica Capasso, et al.
Blood|April 5, 2011
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesisSimona Pisanti, Paola Picardi, Lucia Prota, et al.
Plos One|March 13, 2020
Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy dataGiuseppe Roberto, Andrea Spini, Claudia Bartolini, et al.
Pharmacological Research|August 28, 2021
Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equityAndrea Spini, Valentina Giudice, Vincenzo Brancaleone, et al.
European Journal of Medicinal Chemistry|October 27, 2004
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell lineSilvia Schenone, Olga Bruno, Francesco Bondavalli, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|December 25, 2009
The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeabilityLucia Morbidelli, Anastasia Pyriochou, Sandra Filippi, et al.
American Journal of Ophthalmology|November 21, 2022
Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort StudyAndrea Spini, Sabrina Giometto, Sandra Donnini, et al.
Frontiers in Oncology|June 16, 2023
Validity of Italian administrative healthcare data in describing the real-world utilization of infusive antineoplastic drugs: the study case of rituximab use in patients treated at the University Hospital of Siena for onco-haematological indicationsClaudia Bartolini, Giuseppe Roberto, Anna Girardi, et al.
Pageof 10